STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease

Perminder S Sachdev¹, Jessica W Lo², John D Crawford², Lisa Mellon³, Anne Hickey³, David Williams⁴, Régis Bordet⁵, Anne-Marie Mendyk⁵, Patrick Gelé⁶, Dominique Deplanque⁶, Hee-Joon Bae⁷, Jae-Sung Lim⁸, Amy Brodtmann⁹, Emilio Werden⁹, Toby Cumming⁹, Sebastian Köhler¹⁰, Frans R J Verhey¹⁰, Yan-Hong Dong¹¹, Hui Hui Tan¹², Christopher Chen¹³, Xu Xin¹³, Raj N Kalaria¹⁴, Louise M Allan¹⁴, Rufus O Akinyemi¹⁵, Adesola Ogunniyi¹⁶, Aleksandra Klimkowicz-Mrowiec¹⁷, Martin Dichgans¹⁸, Frank A Wollenweber¹⁹, Vera Zietemann¹⁹, Michael Hoffmann²⁰, David W Desmond²¹, Thomas Linden²², Christian Blomstrand²³, Björn Fagerberg²⁴, Ingmar Skoog²⁵, Olivier Godefroy²⁶, Mélanie Barbay²⁶, Martine Roussel²⁶, Byung-Chul Lee⁸, Kyung-Ho Yu⁸, Joanna Wardlaw²⁷, Stephen J Makin²⁸, Fergus N Doubal²⁷, Francesca M Chappell²⁷, Velandai K Srikanth²⁹, Amanda G Thrift³⁰, Geoffrey A Donnan⁹, Nagaendran Kandiah³¹, Russell J Chander³¹, Xuling Lin³¹, Charlotte Cordonnier⁵, Solene Moulin⁵, Costanza Rossi⁵, Behnam Sabayan³², David J Stott³³, J Wouter Jukema³⁴, Susanna Melkas³⁵, Hanna Jokinen³⁵, Timo Erkinjuntti³⁵, Vincent C T Mok³⁶, Adrian Wong³⁶, Bonnie Y K Lam³⁶, Didier Leys⁵, Hilde Hénon⁵, Stéphanie Bombois⁵, Darren M Lipnicki², Nicole A Kochan²; STROKOG

Collaborators, Affiliations

Collaborators

STROKOG:
Perminder S Sachdev, Jessica W Lo, John D Crawford, Darren M Lipnicki, Nicole A Kochan, Lisa Mellon, Anne Hickey, David Williams, Régis Bordet, Anne-Marie Mendyk, Patrick Gelé, Dominique Deplanque, Hee-Joon Bae, Jae-Sung Lim, Amy Brodtmann, Emilio Werden, Toby Cumming, Sebastian Köhler, Frans Rj Verhey, Yan-Hong Dong, Jing Xu, Christopher Chen, Raj N Kalaria, Louise M Allan, Rufus Akinyemi, Adesola Ogunniyi, Raj N Kalariai, Aleksandra Klimkowicz-Mrowiec, Martin Dichgans, Frank A Wollenweber, Vera Zietemann, Michael Hoffmann, David W Desmond, Thomas Linden, Christian Blomstrand, Björn Fagerberg, Ingmar Skoog, Olivier Godefroy, Mélanie Barbay, Martine Roussel, Byung-Chul Lee, Kyung-Ho Yu, Jae-Sung Lim, Joanna Wardlaw, Stephen J Makin, Fergus N Doubal, Francesca M Chappell, Velandai K Srikanth, Amanda G Thrift, Geoffrey A Donnan, Nagaendran Kandiah, Russell J Chander, Xuling Lin, Charlotte Cordonnier, Solene Moulin, Costanza Rossi, Behnam Sabayan, David J Stott, J Wouter Jukema, Susanna Melkas, Hanna Jokinen, Timo Erkinjuntti, Vincent Ct Mok, Adrian Wong, Bonnie Yk Lam, Didier Leys, Hilde Hénon, Stéphanie Bombois, Perminder Sachdev

Affiliations

¹ Centre for Healthy Brain Ageing (CHeBA), University of New South Wales, Sydney, Australia; Dementia Collaborative Research Centre, University of New South Wales, Sydney, Australia.
² Centre for Healthy Brain Ageing (CHeBA), University of New South Wales, Sydney, Australia.
³ Department of Psychology, Royal College of Surgeons in Ireland, Dublin, Ireland.
⁴ Department of Stroke and Geriatric Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
⁵ University of Lille, Inserm, CHU Lille, U1171 - Degenerative & Vascular Cognitive Disorders, Lille, France.
⁶ University of Lille, Inserm, CHU Lille, CIC 1403 - Centre d'investigation clinique, Lille, France.
⁷ Department of Neurology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea; Clinical Neuroscience Center, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
⁸ Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.
⁹ Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia.
¹⁰ School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
¹¹ Centre for Healthy Brain Ageing (CHeBA), University of New South Wales, Sydney, Australia; Dementia Collaborative Research Centre, University of New South Wales, Sydney, Australia; Memory Ageing and Cognition Center, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Medicine (Neurology Division), Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
¹² Memory Ageing and Cognition Center, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Medicine (Neurology Division), Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
¹³ Memory Ageing and Cognition Center, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
¹⁴ Neurovascular Research Group, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
¹⁵ Neuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training College of Medicine, University of Ibadan, Ibadan, Nigeria.
¹⁶ Neuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training College of Medicine, University of Ibadan, Ibadan, Nigeria; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
¹⁷ Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.
¹⁸ Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
¹⁹ Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University, Munich, Germany.
²⁰ Cognitive Neurology and Stroke Programs, University of Central Florida, Orlando VA Medical Center, Orlando, Florida, USA.
²¹ No Affiliation.
²² Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia; Institute of Neuroscience and Physiology, Centre of Brain Research and Rehabilitation, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Hunter Medical Research Institute, Newcastle, NSW, Australia.
²³ Institute of Neuroscience and Physiology, Centre of Brain Research and Rehabilitation, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
²⁴ Department of Molecular and Clinical Medicine, Wallenberg Laboratory for Cardiovascular and Metabolic Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
²⁵ Institute of Neuroscience and Physiology, Center for Health and Ageing AGECAP, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
²⁶ Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens, France.
²⁷ Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
²⁸ Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK.
²⁹ Peninsula Clinical School, Central Clinical School, Monash University, Melbourne, Australia; Menzies Institute for Medical Research, University of Tasmania, Tasmania, Australia.
³⁰ Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea; Peninsula Clinical School, Central Clinical School, Monash University, Melbourne, Australia.
³¹ Department of Neurology, National Neuroscience Institute, Singapore.
³² Department of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, the Netherlands.
³³ Academic Section of Geriatrics, University of Glasgow, Glasgow, United Kingdom.
³⁴ Department of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands.
³⁵ Clinical Neurosciences, Neurology, University of Helsinki and Helsinki University Hospital, Finland.
³⁶ Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; Therese Pei Fong Chow Research Centre for Prevention of Dementia, Hong Kong SAR, China.

PMID: 28138511
PMCID: PMC5257024
DOI: 10.1016/j.dadm.2016.10.006

STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease

Perminder S Sachdev et al. Alzheimers Dement (Amst). 2016.

. 2016 Nov 18:7:11-23.

doi: 10.1016/j.dadm.2016.10.006. eCollection 2017.

Authors

Collaborators

STROKOG:
Perminder S Sachdev, Jessica W Lo, John D Crawford, Darren M Lipnicki, Nicole A Kochan, Lisa Mellon, Anne Hickey, David Williams, Régis Bordet, Anne-Marie Mendyk, Patrick Gelé, Dominique Deplanque, Hee-Joon Bae, Jae-Sung Lim, Amy Brodtmann, Emilio Werden, Toby Cumming, Sebastian Köhler, Frans Rj Verhey, Yan-Hong Dong, Jing Xu, Christopher Chen, Raj N Kalaria, Louise M Allan, Rufus Akinyemi, Adesola Ogunniyi, Raj N Kalariai, Aleksandra Klimkowicz-Mrowiec, Martin Dichgans, Frank A Wollenweber, Vera Zietemann, Michael Hoffmann, David W Desmond, Thomas Linden, Christian Blomstrand, Björn Fagerberg, Ingmar Skoog, Olivier Godefroy, Mélanie Barbay, Martine Roussel, Byung-Chul Lee, Kyung-Ho Yu, Jae-Sung Lim, Joanna Wardlaw, Stephen J Makin, Fergus N Doubal, Francesca M Chappell, Velandai K Srikanth, Amanda G Thrift, Geoffrey A Donnan, Nagaendran Kandiah, Russell J Chander, Xuling Lin, Charlotte Cordonnier, Solene Moulin, Costanza Rossi, Behnam Sabayan, David J Stott, J Wouter Jukema, Susanna Melkas, Hanna Jokinen, Timo Erkinjuntti, Vincent Ct Mok, Adrian Wong, Bonnie Yk Lam, Didier Leys, Hilde Hénon, Stéphanie Bombois, Perminder Sachdev

Affiliations

¹ Centre for Healthy Brain Ageing (CHeBA), University of New South Wales, Sydney, Australia; Dementia Collaborative Research Centre, University of New South Wales, Sydney, Australia.
² Centre for Healthy Brain Ageing (CHeBA), University of New South Wales, Sydney, Australia.
³ Department of Psychology, Royal College of Surgeons in Ireland, Dublin, Ireland.
⁴ Department of Stroke and Geriatric Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
⁵ University of Lille, Inserm, CHU Lille, U1171 - Degenerative & Vascular Cognitive Disorders, Lille, France.
⁶ University of Lille, Inserm, CHU Lille, CIC 1403 - Centre d'investigation clinique, Lille, France.
⁷ Department of Neurology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea; Clinical Neuroscience Center, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
⁸ Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.
⁹ Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia.
¹⁰ School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
¹¹ Centre for Healthy Brain Ageing (CHeBA), University of New South Wales, Sydney, Australia; Dementia Collaborative Research Centre, University of New South Wales, Sydney, Australia; Memory Ageing and Cognition Center, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Medicine (Neurology Division), Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
¹² Memory Ageing and Cognition Center, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Medicine (Neurology Division), Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
¹³ Memory Ageing and Cognition Center, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
¹⁴ Neurovascular Research Group, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
¹⁵ Neuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training College of Medicine, University of Ibadan, Ibadan, Nigeria.
¹⁶ Neuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training College of Medicine, University of Ibadan, Ibadan, Nigeria; Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
¹⁷ Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.
¹⁸ Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
¹⁹ Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University, Munich, Germany.
²⁰ Cognitive Neurology and Stroke Programs, University of Central Florida, Orlando VA Medical Center, Orlando, Florida, USA.
²¹ No Affiliation.
²² Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia; Institute of Neuroscience and Physiology, Centre of Brain Research and Rehabilitation, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Hunter Medical Research Institute, Newcastle, NSW, Australia.
²³ Institute of Neuroscience and Physiology, Centre of Brain Research and Rehabilitation, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
²⁴ Department of Molecular and Clinical Medicine, Wallenberg Laboratory for Cardiovascular and Metabolic Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
²⁵ Institute of Neuroscience and Physiology, Center for Health and Ageing AGECAP, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
²⁶ Department of Neurology and Laboratory of Functional Neurosciences, University Hospital of Amiens, France.
²⁷ Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
²⁸ Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK.
²⁹ Peninsula Clinical School, Central Clinical School, Monash University, Melbourne, Australia; Menzies Institute for Medical Research, University of Tasmania, Tasmania, Australia.
³⁰ Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea; Peninsula Clinical School, Central Clinical School, Monash University, Melbourne, Australia.
³¹ Department of Neurology, National Neuroscience Institute, Singapore.
³² Department of Gerontology and Geriatrics, Leiden University Medical Centre, Leiden, the Netherlands.
³³ Academic Section of Geriatrics, University of Glasgow, Glasgow, United Kingdom.
³⁴ Department of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands.
³⁵ Clinical Neurosciences, Neurology, University of Helsinki and Helsinki University Hospital, Finland.
³⁶ Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; Therese Pei Fong Chow Research Centre for Prevention of Dementia, Hong Kong SAR, China.

PMID: 28138511
PMCID: PMC5257024
DOI: 10.1016/j.dadm.2016.10.006

Abstract

Introduction: The Stroke and Cognition consortium (STROKOG) aims to facilitate a better understanding of the determinants of vascular contributions to cognitive disorders and help improve the diagnosis and treatment of vascular cognitive disorders (VCD).

Methods: Longitudinal studies with ≥75 participants who had suffered or were at risk of stroke or TIA and which evaluated cognitive function were invited to join STROKOG. The consortium will facilitate projects investigating rates and patterns of cognitive decline, risk factors for VCD, and biomarkers of vascular dementia.

Results: Currently, STROKOG includes 25 (21 published) studies, with 12,092 participants from five continents. The duration of follow-up ranges from 3 months to 21 years.

Discussion: Although data harmonization will be a key challenge, STROKOG is in a unique position to reuse and combine international cohort data and fully explore patient level characteristics and outcomes. STROKOG could potentially transform our understanding of VCD and have a worldwide impact on promoting better vascular cognitive outcomes.

Keywords: Cohort studies; Data harmonization; International consortium; Post-stroke dementia; Small vessel disease; Vascular cognitive disorder; Vascular dementia.

PubMed Disclaimer

References

1. Román G.C. Science Press; London: 2003. Managing Vascular Dementia.
1. Lobo A., Launer L.J., Fratiglioni L., Andersen K., Di Carlo A., Breteler M.M. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54:S4–S9. - PubMed
1. Rockwood K., Wentzel C., Hachinski V., Hogan D.B., MacKnight C., McDowell I. Prevalence and outcomes of vascular cognitive impairment. Neurology. 2000;54:447–451. - PubMed
1. Pohjasvaara T., Erkinjuntti T., Ylikoski R., Hietanen M., Vataja R., Kaste M. Clinical determinants of poststroke dementia. Stroke. 1998;29:75–81. - PubMed
1. Sachdev P.S., Brodaty H., Valenzuela M.J., Lorentz L., Looi J.C.L., Berman K. Clinical determinants of dementia and mild cognitive impairment following ischaemic stroke: the Sydney Stroke Study. Dement Geriatr Cogn Disord. 2006;21:275–283. - PubMed

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease

Collaborators

Affiliations

STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease

Authors

Collaborators

Affiliations

Abstract

References

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources